- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Estrogen receptor alpha (ESR1) is a ligand-activated nuclear hormone receptor that regulates gene transcription in response to estrogen signaling and plays a central role in the growth and differentiation of hormone-responsive tissues. ESR1 is widely expressed in breast epithelial cells and is a key driver of estrogen-dependent gene expression, controlling processes such as cellular proliferation, differentiation, and survival. Upon binding estrogen, ESR1 undergoes conformational changes that promote dimerization, nuclear localization, and interaction with estrogen response elements, leading to activation of downstream target genes.
Estrogen Receptor alpha antibody, also referred to as ESR1 antibody, ER alpha antibody, and ERa antibody in the literature, recognizes a nuclear receptor that is widely used as a biomarker in breast cancer research. ESR1 expression is a defining feature of hormone receptor-positive breast tumors, where it is used to classify tumor subtype and guide therapeutic decision-making. Detection of ESR1 is therefore critical for studying tumor biology, endocrine responsiveness, and resistance mechanisms associated with hormone-based therapies.
This Estrogen Receptor alpha Antibody / ESR1 Hormone Receptor and Breast Cancer Marker Antibody (clone ESR1/3557) is uniquely positioned for comprehensive analysis of ESR1 expression across multiple experimental systems. ESR1 is predominantly localized to the nucleus in epithelial and tumor cells, reflecting its role as a transcription factor, although dynamic redistribution can occur depending on signaling context. This antibody supports detection of ESR1 in tissue-based studies, cellular imaging, protein analysis, and single-cell assays, enabling integrated evaluation of receptor expression and function across diverse biological models.
In immunohistochemistry, ESR1 is typically observed as strong nuclear staining in hormone-responsive tissues and breast carcinoma samples, providing clear distinction between positive tumor cells and surrounding stromal compartments. In immunofluorescence, ESR1 localization is similarly nuclear, while flow cytometry applications require fixation and permeabilization for intracellular detection of the receptor. Western blot analysis typically reveals a band corresponding to the expected molecular weight of ESR1, supporting confirmation of protein expression across cell types and treatment conditions.
Microarray validation of clone ESR1/3557 supports its specificity for the ESR1 protein, providing confidence in target recognition across a broad range of human proteins. As a mouse monoclonal antibody, clone ESR1/3557 offers reproducible performance for detecting Estrogen receptor alpha in research applications. An Estrogen Receptor alpha antibody is suitable for detecting ESR1 expression in studies of hormone signaling, breast cancer biology, and transcriptional regulation.
HER2 is commonly evaluated alongside this marker in epithelial tumors and breast cancer research; see our HER2 antibody page. This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Optimal dilution of the Estrogen Receptor alpha Antibody / ESR1 Hormone Receptor and Breast Cancer Marker Antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A recombinant human ESR1 protein fragment within amino acids 129-312 was used as the immunogen for the Estrogen Receptor alpha antibody microarray validated clone ESR1/3557.
Store the Estrogen Receptor alpha antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Estrogen receptor alpha antibody, ESR1 antibody, ER alpha antibody, ERa antibody, ESR1 breast cancer marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.